About
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.
Key Metrics
as of Sep 2026Market Cap33,669 Cr
P/E91.60
Div Yield0.00 %
Book Value₹117.00
52w High₹1,630.00
52w Low₹784.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 547.00 | 594.00 | 549.00 | 527.00 | 483.00 | 567.00 | 429.00 | 382.00 | 264.00 | 428.00 | 373.00 |
| Expenses | 407.00 | 426.00 | 370.00 | 387.00 | 370.00 | 413.00 | 317.00 | 281.00 | 240.00 | 301.00 | 279.00 |
| Operating Profit | 140.00 | 168.00 | 179.00 | 140.00 | 113.00 | 154.00 | 111.00 | 101.00 | 25.00 | 127.00 | 94.00 |
| OPM % | 26.00 | 28.00 | 33.00 | 27.00 | 23.00 | 27.00 | 26.00 | 26.00 | 9.00 | 30.00 | 25.00 |
| Other Income | 4.00 | 16.00 | 0.00 | 15.00 | 10.00 | 10.00 | 9.00 | 10.00 | 8.00 | 4.00 | 11.00 |
| Depreciation | 42.00 | 41.00 | 41.00 | 36.00 | 34.00 | 34.00 | 31.00 | 33.00 | 28.00 | 28.00 | 28.00 |
| Interest | 6.00 | 6.00 | 8.00 | 8.00 | 11.00 | 9.00 | 22.00 | 19.00 | 20.00 | 19.00 | 22.00 |
| Profit before tax | 95.00 | 137.00 | 130.00 | 111.00 | 78.00 | 120.00 | 68.00 | 58.00 | -15.00 | 83.00 | 54.00 |
| Tax % | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | -25.00 | 26.00 | 26.00 |
| Net Profit | 71.00 | 103.00 | 98.00 | 83.00 | 58.00 | 90.00 | 51.00 | 44.00 | -11.00 | 62.00 | 40.00 |
| EPS in Rs | 3.36 | 4.84 | 4.62 | 3.95 | 2.80 | 4.32 | 2.45 | — | — | — | — |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,153.00 | 1,642.00 | 1,419.00 | 1,157.00 | 841.00 | 751.00 | 725.00 | 695.00 |
| Expenses | 1,551.00 | 1,248.00 | 1,131.00 | 990.00 | 716.00 | 587.00 | 556.00 | 520.00 |
| Operating Profit | 602.00 | 394.00 | 288.00 | 167.00 | 125.00 | 164.00 | 170.00 | 175.00 |
| OPM % | 28.00 | 24.00 | 20.00 | 14.00 | 15.00 | 22.00 | 23.00 | 25.00 |
| Other Income | 40.00 | 36.00 | 29.00 | 27.00 | 28.00 | 27.00 | 18.00 | 6.00 |
| Interest | 34.00 | 72.00 | 81.00 | 74.00 | 51.00 | 32.00 | 21.00 | 24.00 |
| Depreciation | 152.00 | 126.00 | 107.00 | 88.00 | 80.00 | 72.00 | 52.00 | 44.00 |
| Profit before tax | 456.00 | 232.00 | 129.00 | 33.00 | 22.00 | 88.00 | 114.00 | 112.00 |
| Tax % | 25.00 | 25.00 | 26.00 | 26.00 | 30.00 | 25.00 | 30.00 | 35.00 |
| Net Profit | 341.00 | 173.00 | 95.00 | 24.00 | 16.00 | 65.00 | 80.00 | 73.00 |
| EPS in Rs | 16.12 | 8.32 | — | — | — | — | — | — |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 279.00 | 444.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21.00 | 21.00 | 18.00 | 18.00 | 18.00 | 18.00 | 16.00 | 16.00 |
| Reserves | 2,487.00 | 2,147.00 | 993.00 | 895.00 | 873.00 | 850.00 | 778.00 | 700.00 |
| Borrowings | 223.00 | 287.00 | 868.00 | 869.00 | 752.00 | 637.00 | 304.00 | 250.00 |
| Other Liabilities | 872.00 | 682.00 | 361.00 | 349.00 | 464.00 | 312.00 | 291.00 | 246.00 |
| Total Liabilities | 3,603.00 | 3,137.00 | 2,240.00 | 2,131.00 | 2,106.00 | 1,816.00 | 1,389.00 | 1,212.00 |
| Fixed Assets | 1,705.00 | 1,378.00 | 1,074.00 | 923.00 | 701.00 | 659.00 | 617.00 | 373.00 |
| CWIP | 270.00 | 124.00 | 107.00 | 151.00 | 345.00 | 236.00 | 79.00 | 116.00 |
| Investments | 163.00 | 114.00 | 80.00 | 80.00 | 64.00 | 63.00 | 22.00 | 0.00 |
| Other Assets | 1,465.00 | 1,521.00 | 979.00 | 977.00 | 996.00 | 858.00 | 671.00 | 722.00 |
| Total Assets | 3,603.00 | 3,137.00 | 2,240.00 | 2,131.00 | 2,106.00 | 1,816.00 | 1,389.00 | 1,212.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 495.00 | 330.00 | 251.00 | 221.00 | 88.00 | -26.00 | 109.00 | 127.00 |
| Cash from Investing Activity | -393.00 | -565.00 | -190.00 | -111.00 | -95.00 | -279.00 | -259.00 | -158.00 |
| Cash from Financing Activity | -109.00 | 314.00 | -85.00 | -190.00 | 81.00 | 304.00 | -1.00 | 268.00 |
| Net Cash Flow | -7.00 | 80.00 | -24.00 | -80.00 | 75.00 | -2.00 | -152.00 | 237.00 |
| Free Cash Flow | -94.00 | -33.00 | 72.00 | 156.00 | -109.00 | -267.00 | -139.00 | -30.00 |
| CFO/OP % | 89.00 | 89.00 | 92.00 | 135.00 | 77.00 | -6.00 | 75.00 | 89.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63.00 | 78.00 | 67.00 | 87.00 | 103.00 | 98.00 | 136.00 | 123.00 |
| Inventory Days | 98.00 | 96.00 | 73.00 | 123.00 | 185.00 | 124.00 | 77.00 | 86.00 |
| Days Payable | 200.00 | 270.00 | 114.00 | 176.00 | 284.00 | 244.00 | 247.00 | 208.00 |
| Cash Conversion Cycle | -40.00 | -96.00 | 25.00 | 35.00 | 4.00 | -21.00 | -34.00 | 0.00 |
| Working Capital Days | 68.00 | 69.00 | 20.00 | 42.00 | 49.00 | 60.00 | 32.00 | 55.00 |
| ROCE % | 19.00 | 14.00 | 11.00 | 6.00 | 4.00 | 9.00 | 13.00 | — |
Corporate Actions
No corporate actions recorded.
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update26 Feb from icra
-
Rating update14 Aug 2025 from fitch
-
Rating update15 May 2024 from fitch
-
Rating update28 Feb 2023 from fitch
-
Rating update8 Dec 2021 from fitch
-
Rating update31 Mar 2021 from care